approval
saveMYCOPHENOLATE MOFETIL — FDA approval
community read0 votes
Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalMYCOPHENOLATE MOFETIL — FDA approvalApr 10, 2026 · 184d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalMar 18, 2026 · 207d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalFeb 23, 2026 · 230d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalJan 14, 2026 · 270d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalJan 14, 2026 · 270d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalSep 26, 2024 · 745d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalAug 13, 2024 · 789d ago
- approvalMYCOPHENOLATE MOFETIL — FDA approvalAug 13, 2024 · 789d ago
same company · ±60 days · 6
- approvalMYCOPHENOLATE MOFETIL: MYCOPHENOLATE MOFETIL — FDA approvalAug 13, 2024
- approvalmycophenolate sodium DR: MYCOPHENOLATE SODIUM — FDA approvalAug 13, 2024
- approvalVIGABATRIN: VIGABATRIN — FDA approvalSep 12, 2024
- approvalVIGABATRIN: VIGABATRIN — FDA approvalSep 12, 2024
- approvalERTUGLIFLOZIN: ERTUGLIFLOZIN — FDA approvalJul 11, 2024
- approvalMYCOPHENOLATE MOFETIL: MYCOPHENOLATE MOFETIL — FDA approvalSep 26, 2024
comments(0)
5-min edit window · permanent after that